Effect of feline interferon-omega on the survival time and quality of life of cats with feline infectious peritonitis

Journal of Veterinary Internal Medicine

Volumn 21, Issue 6, 2007, Pages 1193-1197

  Ritz, Susanne ^a   Egberink, Herman ^b   Hartmann, Katrin ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Feline coronavirus (FCoV); Glucocorticoids; Therapy; Treatment

Indexed keywords

ANTIVIRUS AGENT; INTERFERON; INTERFERON OMEGA 1; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CAT; CAT DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; MALE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

ANIMALS; ANTIVIRAL AGENTS; CATS; DOUBLE-BLIND METHOD; FELINE INFECTIOUS PERITONITIS; FEMALE; INTERFERON TYPE I; MALE; QUALITY OF LIFE; RECOMBINANT PROTEINS; SURVIVAL ANALYSIS;

ANIMALIA; CORONAVIRUS; FELIDAE; FELINE CORONAVIRUS;

EID: 37349011167     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/06-302.1     Document Type: Article

References (22)

1. Rohrbach BW, Legendre AM, Baldwin CA, et al. Epidemiology of feline infectious peritonitis among cats examined at veterinary medical teaching hospitals. J Am Vet Med Assoc 2001;218:1111-1115.
2. Pedersen NC. Virologic and immunologic aspects of feline infectious peritonitis virus infection. Adv Exp Med Biol 1987;218:529-550.
3. Pedersen NC, Black JW, Boyle JF, et al. Pathogenic differences between various feline coronavirus isolates. Adv Exp Med Biol 1984;173:365-380.
4. Herrewegh AA, Smeenk I, Horzinek MC, et al. Feline coronavirus type II strains 79-1683 and 79-1146 originate from a double recombination between feline coronavirus type I and canine coronavirus. J Virol 1998;72:4508-4514.
5. Robison RL, Holzworth J, Gilmore CE. Naturally occurring feline infectious peritonitis: Signs and clinical diagnosis. J Am Vet Med Assoc 1971;158:981-986.
6. Hartmann K, Binder C, Hirschberger J, et al. Comparison of different tests to diagnose feline infectious peritonitis. J Vet Intern Med 2003;17:781-790.
7. Tammer R, Evensen O, Lutz H, et al. Immunohistological demonstration of feline infectious peritonitis virus antigen in paraffin-embedded tissues using feline ascites or murine monoclonal antibodies. Vet Immunol Immunopathol 1995;49:177-182.
8. Ishida T, Shibanai A, Tanaka S, et al. Use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis. J Feline Med Surg 2004;6:107-109.
9. Hartmann K, Kuffer M. Karnofsky's score modified for cats. Eur J Med Res 1998;3:95-98.
10. Walter JH, Rudolph R. The frequency and pathogenesis of feline infectious peritonitis (FIP) (in German). Dtsch Tierarztl Wochenschr 1989;96:194-196, 201.
11. Lutz H, Hauser B, Horzinek MC. Feline infectious peritonitis (FIP): The present state of knowledge. J Small Anim Pract 1986;27:108-116.
12. McReynolds C, Macy D. Feline infectious peritonitis. Part I. Etiology and diagnosis. Comp Cont Educ Pract Vet 1997; 19:1007-1016.
13. Ueda Y, Sakurai T, Kasama K, et al. Pharmacokinetic properties of recombinant feline interferon and its stimulatory effect on 2′,5′- oligoadenylate synthetase activity in the cat. J Vet Med Sci 1993;55:1-6.
14. Weiss RC, Cox NR, Oostrom-Ram T. Effect of interferon or Propionibacterium acnes on the course of experimentally induced feline infectious peritonitis in specific-pathogen-free and random-source cats. Am J Vet Res 1990;51:726-733.
15. Hohdatsu T, Okada S, Ishizuka Y, et al. The prevalence of types I and II feline coronavirus infections in cats. J Vet Med Sci 1992;54:557-562.
16. Benetka V, Kubber-Heiss A, Kolodziejek J, et al. Prevalence of feline coronavirus types I and II in cats with histopathologically verified feline infectious peritonitis. Vet Microbiol 2004;99:31-42.
17. Brooks BM, Hart CA, Coleman JW. Differential effects of β-lactams on human IFN-γ activity. J Antimicrob Chemother 2005;56:1122-1125.
18. Dufour V, Millon L, Faucher J-F, et al. Effects of a short-course of amoxicillin/clavulanic acid on systemic and mucosal immunity in healthy adult humans. Int Immunopharmacol 2005; 5:917-928.
19. Kyuwa S, Tagawa Y, Machii K, et al. MHV-induced fatal peritonitis in mice lacking IFN-gamma. Adv Exp Med Biol 1998;440:445-450.
20. Bertens AP. Passive and active immunization against feline enteritis and rhinotracheitis in experimental cats (in Dutch). Tijdschr Diergeneeskd 1979;104:107-110.
21. Weiss RC, Oostrom-Ram T. Inhibitory effects of ribavirin alone or combined with human alpha interferon on feline infectious peritonitis virus replication in vitro. Vet Microbiol 1989;20: 255-265.
22. Bölcskei A, Bilkei G. Langzeitstudie über behandelte FIP-verdächtige Katzen. Tierärztl Umschau 1995;50:721-728.